SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-23-009282
Filing Date
2023-08-03
Accepted
2023-08-03 16:59:45
Documents
16
Period of Report
2023-08-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT admp-8k_080123.htm   iXBRL 8-K 58452
2 PLACEMENT AGENCY AGREEMENT ex1-1.htm EX-1.1 62472
3 OPINION OF WEINTRAUB TOBIN CHEDIAK COLEMAN GRODIN ex5-1.htm EX-5.1 16894
4 SECURITIES PURCHASE AGREEMENT ex10-1.htm EX-10.1 222320
5 PRESS RELEASE ex99-1.htm EX-99.1 12090
  Complete submission text file 0001387131-23-009282.txt   644220

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT admp-20230801.xsd EX-101.SCH 2998
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT admp-20230801_lab.xml EX-101.LAB 34240
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT admp-20230801_pre.xml EX-101.PRE 22385
10 EXTRACTED XBRL INSTANCE DOCUMENT admp-8k_080123_htm.xml XML 3601
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36242 | Film No.: 231141015
SIC: 2834 Pharmaceutical Preparations